Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multifocal vs single-vision soft contact lenses with or without low-dose atropine for myopia control in schoolchildren
jRCTs032200060Active, not recruiting
- Sponsor
- Johnson & Johnson
- Start
- Aug 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of atropine in myopia (4 arms), sponsored by Johnson & Johnson. Primary endpoint: Primary: Axial elongation and myopia progression (Group A vs Group B). Started Aug 2021; status: active, not recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on jRCTs032200060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs032200060.